Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
about
Management of bleeding and coagulopathy following major trauma: an updated European guideline.Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophiliaNew trends in resuscitationEarly and individualized goal-directed therapy for trauma-induced coagulopathyThe European guideline on management of major bleeding and coagulopathy following trauma: fourth editionMass casualty events: blood transfusion emergency preparedness across the continuum of care.Medical aspects of terrorist bombings - a focus on DCS and DCR.The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII.Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital recordsUse of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injuryRecombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.Coagulopathy following major trauma hemorrhage: lytic, lethal and a lack of fibrinogenThe acute management of trauma hemorrhage: a systematic review of randomized controlled trialsSystematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indicationsProphylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis.Recombinant factor VII is associated with worse survival in complex cardiac surgical patientsModulation of syndecan-1 shedding after hemorrhagic shock and resuscitation.Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementationDamage control - trauma care in the first hour and beyond: a clinical review of relevant developments in the field of trauma care.Fibrinogen concentrate improves survival during limited resuscitation of uncontrolled hemorrhagic shock in a Swine model.The spot sign predicts hematoma expansion, outcome, and mortality in patients with primary intracerebral hemorrhageLiver trauma: WSES position paperRecombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patientsSpanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.Risk factors for trauma-induced coagulopathy- and transfusion-associated multiple organ failure in severely injured trauma patients.Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.The pathophysiology, diagnosis and treatment of the acute coagulopathy of trauma and shock: a literature review.Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe HypothermiaUse of Activated Recombinant Factor VII in Severe Bleeding - Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding.Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy.Clinical review: Canadian National Advisory Committee on Blood and Blood Products--Massive transfusion consensus conference 2011: report of the panel.The utility of recombinant factor VIIa as a last resort in trauma.The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework.Interventional Algorithms for the Control of Coagulopathic Bleeding in Surgical, Trauma, and Postpartum Settings: Recommendations From the Share Network GroupRediscovering the wound hematoma as a site of hemostasis during major arterial hemorrhageThe use of massive transfusion protocol for trauma and non-trauma patients in a civilian setting: what can be done better?A pediatric massive transfusion protocol.Development and validation of a prehospital prediction model for acute traumatic coagulopathy.New evidence in trauma resuscitation - is 1:1:1 the answer?
P2860
Q21092902-53CDB67D-2D0B-4D0C-B212-6734E26FFB86Q24201292-3DDE1697-6A46-491A-BBF5-7A738A25659FQ24599047-D1D46BE3-1C12-4F2E-A7E2-C4E5689F05A6Q26853422-C3D36A12-C966-4832-9500-1F18C17322B5Q27339343-C069EA85-73E6-4933-98EC-FEE07E50E40FQ30152076-01677071-97E5-4EC4-A6D4-3BA829EAE042Q30204597-32D8F7FB-D38B-4631-9419-0038014980C5Q30833127-6DB7A2D5-A2B9-435F-973D-5D79C430D725Q33571590-86F545FF-A90A-41BB-8C78-AF01A33DE246Q33581052-1E1BEFFC-FD21-4766-924D-EDB971534FFEQ33756657-E70FE39F-13D9-4BD7-B076-DAFB63477163Q33822672-DB44AD1E-FFC7-479F-A986-7B303DB5EB3FQ33842873-51A65867-B8FB-49B2-9207-AEA1A8237D06Q33876266-5F9ED69F-C40C-4BC6-91A0-8CE697571236Q33983293-420EA53D-A8C1-43B9-A211-9FF12D35BBCEQ34005911-0B892971-EABC-4DEE-9A4E-2043BBE6212EQ34008848-16C2E7B6-C7B7-48AE-9BA4-C68C775F513CQ34064066-5E1AC727-9311-4FC0-995C-5F3AA4FA2CCFQ34192917-F445F500-2B07-443E-891E-6591EC11D69DQ34390320-C8F4426D-24FC-48FE-9FD4-90266EAC920AQ34447657-177DE71B-5D94-461D-98B3-A338DCDD82FAQ34491055-E38EA553-D2F5-4757-81E0-36C1E6972145Q34604004-961D494D-78EE-4388-A4F9-582D01263EC9Q34654443-0E6D1B07-9E94-4FE5-B924-B6699C207CFBQ35219638-A6549A99-0465-4140-BF3A-583E469054F7Q35535096-15157526-341C-48EB-BD82-165E3348D8BBQ35559379-9B5A5884-1BA2-4DFE-80AE-E14A96F0A506Q35650554-3B39EBE7-4CE6-43D8-8D79-31E478B2761EQ35670503-C60B70F0-F407-47C6-B556-3BB397F5BC1FQ35998366-9C0585B9-1C5C-4610-80F3-4E78F65A69C0Q35998384-A9F3CFFF-6127-4390-A176-87241EBBD5CBQ36073080-4142F812-8F0B-4A06-8BDB-67288176BD12Q36181277-862AA2B0-B5E1-4AE8-8882-6BC83B6E2EA7Q36537350-437EDD1D-5918-465A-B48B-93497D7F2339Q36543599-339609D0-A6F6-4B3F-82DC-34C7DB4421F1Q36649008-4219CF87-574E-46D6-930C-A07A1535C751Q36925382-0D405EE9-D9EC-4D62-BE95-9BBA714CCA55Q37290077-41621F4A-690B-4153-A560-5FB23118EBEDQ37416991-B0D41AC9-EAC9-42BC-8F74-9EB569D37EADQ37660537-75092FFC-B725-4C99-8438-59AFAB797A3F
P2860
Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Results of the CONTROL trial: ...... fractory traumatic hemorrhage.
@ast
Results of the CONTROL trial: ...... fractory traumatic hemorrhage.
@en
Results of the CONTROL trial: ...... fractory traumatic hemorrhage.
@nl
type
label
Results of the CONTROL trial: ...... fractory traumatic hemorrhage.
@ast
Results of the CONTROL trial: ...... fractory traumatic hemorrhage.
@en
Results of the CONTROL trial: ...... fractory traumatic hemorrhage.
@nl
prefLabel
Results of the CONTROL trial: ...... fractory traumatic hemorrhage.
@ast
Results of the CONTROL trial: ...... fractory traumatic hemorrhage.
@en
Results of the CONTROL trial: ...... fractory traumatic hemorrhage.
@nl
P2093
P50
P1433
P1476
Results of the CONTROL trial: ...... fractory traumatic hemorrhage.
@en
P2093
Ari Leppaniemi
Bartholomew J Tortella
Bertil Bouillon
CONTROL Study Group
Carl J Hauser
Gordon R Bernard
Jeannett Dimsits
Martin A Croce
Michael Parr
Richard Dutton
P304
P356
10.1097/TA.0B013E3181EDF36E
P407
P577
2010-09-01T00:00:00Z